iFlytek Medical Technology Co., Ltd. has established a new subsidiary, Shanghai Yanjin Intelligent Technology Co., Ltd., in Shanghai with a registered capital of 10 million RMB. The new company will focus on artificial intelligence application software development, AI theory and algorithm software development, and remote health management services. This move indicates iFlytek Medical's strategic expansion into AI-driven healthcare solutions. AI
IMPACT Indicates expansion of AI applications in the healthcare sector.
RANK_REASON Company establishing a new subsidiary for AI development.
- iFlytek Medical Technology Co., Ltd.
- OpenAI
- Shanghai Yanjin Intelligent Technology Co., Ltd.
- SK Hynix
AI-generated summary · Google Gemini · from 1 sources. How we write summaries →
